FDA warning letters
A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.
21 letters match. Newest first.
-
DrugsFairyGene, Inc.
FDA cites FairyGene, a Bristol, PA contract manufacturer, for unsanitary facility and cleaning practices and for selling five unapproved drug balms.
High risk -
DrugsCosmetic Manufacturers Pty Ltd.
FDA warned Cosmetic Manufacturers Pty Ltd. that its Australian drug site was adulterated due to CGMP violations and placed its drugs on import alert.
High risk -
DrugsWinder Laboratories, LLC
FDA warns Winder Laboratories of adulterated prescription drugs due to cleaning and facility failures.
High risk -
DrugsKenil Healthcare Private Limited
FDA warns Kenil Healthcare over adulterated drugs from India due to cleaning, packaging, and quality failures.
High risk -
DrugsDyno Manufacturing, Inc.
Dyno Manufacturing’s OTC hand sanitizer and antibacterial soap drugs lacked raw-material identity testing and other required manufacturing controls.
High risk -
DrugsAmWiner & Raphe Holdings, LLC dba rapheGenerics Corp
FDA cited rapheGenerics for manufacturing-quality failures and unapproved minoxidil hair regrowth drugs.
High risk -
DrugsAccupack Midwest, Inc.
Accupack Midwest, an over-the-counter drug contract manufacturer, lacked adequate water controls and process validation.
High risk -
DrugsLS Promotions Inc.
LS Promotions Inc. failed to adequately test and validate its OTC sunscreens, lip balm and hand sanitizer, making them adulterated drugs.
High risk -
DrugsAqualex Co., Ltd.
Aqualex, a Korean contract manufacturer, was cited for manufacturing failures and an unapproved OTC sunscreen with misleading labeling.
High risk -
DrugsHandock Cosmetics Co., Ltd.
FDA warns Handock Cosmetics over manufacturing quality failures and unapproved/mislabeled hand sanitizers from South Korea.
High risk -
DevicesCaltag Medsystems Ltd
FDA warned Caltag Medsystems over quality-system failures in making TransFix/EDTA Vacuum Blood Collection Tubes.
Medium -
DrugsLex Inc.
FDA warns Lex Inc. of Medley, Florida, that its over-the-counter drugs are adulterated because manufacturing rules were not met, including missing toxic-ingredient testing.
High risk -
DrugsCosmetic Science Laboratories LLC
FDA warned Cosmetic Science Laboratories about OTC sunscreen drugs made without required manufacturing controls.
High risk -
DevicesWintech Medipro LLC
FDA warns Wintech Medipro over unapproved surgical masks and broad quality system failures.
High risk -
DrugsAmerican Cleaning Solutions
FDA warned American Cleaning Solutions after a 2022 inspection found hand sanitizer made with inadequate cleaning, unvalidated processes, and substituted ethanol.
High risk -
DrugsVerde Cosmetic Labs LLC
FDA warned Verde Cosmetic Labs after an inspection found inadequate CGMP controls for OTC topical drugs, including cleaning and water system failures.
High risk -
DrugsColorful Products Corporation
FDA warned Colorful Products Corporation about serious current good manufacturing practice (CGMP) failures for its over-the-counter topical drugs and hand sanitizers.
High risk -
DrugsIndiana Chem-Port
Indiana Chem-Port API manufacturer cited for CGMP deviations including dirty equipment, unvalidated processes, and cleaning failures.
High risk -
DrugsProquimes S A Productos Quimicos Especializados S.A.
FDA warned Proquimes S.A. that its active pharmaceutical ingredient manufacturing violated current good manufacturing practice (CGMP) because process, equipment, and cleaning validation were missing.
High risk -
DrugsHonest Globe, Inc.
FDA cited Honest Globe for manufacturing-quality failures and for selling unapproved CBD pain-relief drugs.
High risk -
DrugsDibar Nutricional S. de R.L. de C.V.
Dibar Nutricional's OTC drugs drew FDA CGMP violations and an import alert over missing testing.
High risk